According to the group Allied Market Research, the “U.S. topical pain relief market --valued at $2.6 billion in 2019 --is projected to grow to $3.2 billion by 2027."
The U.S. population is aging. Baby boomers, now numbering close to 70 million, are the country’s second-largest population group and are the largest population group suffering from arthritis and joint pain, currently just over 52 million.
On the economic side, the country's spending on healthcare is expected to grow over 5% per between now and 2031-- at which time it will comprise around 20% of the entire economy. If there was ever a time to seek new ways to restore homeostasis and, thereby, relieve chronic and costly conditions, it is now.
Every medical condition can be traced back to failure at some point in the homeostatic control system, whether it be in the inability to detect the initial external change, failure of initiating a feedback loop, failure to enact a response to return to the setpoint, or failure in the setpoint itself. The goal of next generation treatments must be to restabilize the internal milieu of the body without causing further harm and to do so promptly to avoid the death of cells from apoptosis, and irreparable failure of organ systems. (NIH)
Copyright © 2023 NeoHackLife Sciences, LLC - All Rights Reserved